Rohan Mital Alexander M Cartron John C Trinidad Natalie Spaccarelli I-Sanna Gibbons-Fideler Benjamin H Kaffenberger Catherine G Chung
10.1016/j.jdcr.2022.11.020
JAAD Case Rep
2022 Nov 24;31:124-127.
nsclc, non-small-cell lung cancer pd-1 inhibitor pd1, programmed cell death protein 1 drug eruption fixed drug eruption immunotherapy lichen sclerosus nivolumab pembrolizumab post-herpetic isotopic response pseudolymphoma rash scleredema skin toxicity
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/36583144/
Case Reports
PMC9792734
36583144
Novel cutaneous eruptions in the setting of programmed cell death protein 1 inhibitor therapy
2022